High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 1, 2006, Pages 61-67

  Blum, William ^a   Bolwell, Brian J ^b   Phillips, Gary ^a   Farag, Sherif S ^a   Lin, Thomas S ^a   Avalos, Belinda R ^a   Penza, Sam L ^a   Marcucci, Guido ^a   Byrd, John C ^a   Kalaycio, Matt E ^b   Sobecks, Ronald M ^b   Pohlman, Brad ^b   Brown, Stacey ^b   Elder, Patrick J ^a   Copelan, Edward A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AML; Disease burden; Unrelated donor cell transplantation

Indexed keywords

AMPHOTERICIN; ANTIVIRUS AGENT; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUCONAZOLE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; METHOTREXATE; PENICILLIN V POTASSIUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COUNSELING; DONOR; DRUG DOSE REGIMEN; FOLLOW UP; HIGH RISK PATIENT; HLA MATCHING; HUMAN; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MYELOABLATIVE CONDITIONING; PROGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 29844444304     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.06.004     Document Type: Article

References (21)

1. J.C. Biggs M.M. Horowitz R.P. Gale et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy Blood 80 1992 1090-1093
2. J. Mehta R. Powles C. Horton et al. Bone marrow transplantation for primary refractory acute leukaemia Bone Marrow Transplant 14 1994 415-418
3. R.B. Geller R. Saral S. Piantadosi et al. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia Blood 73 1989 2209-2218
4. M. Michallet X. Thomas J.P. Vernant et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: A retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM) Bone Marrow Transplant 26 2000 1157-1163
5. J. Sierra B. Storer J.A. Hansen et al. Unrelated donor marrow transplantation for acute myeloid leukemia: An update of the Seattle experience Bone Marrow Transplant 26 2000 397-404
6. C. Hallemeier M. Girgis W. Blum et al. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants Biol Blood Marrow Transplant 10 2004 310-319
7. E.A. Copelan J.C. Biggs J.M. Thompson et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2 Blood 78 1991 838-843
8. N. Basara H. Baurmann K. Kolbe et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: Results from the multicenter German cooperative study group Bone Marrow Transplant 35 2005 1011-1018
9. H.C. Fung A. Stein M. Slovak et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome Biol Blood Marrow Transplant 9 2003 766-771
10. M. Kalaycio L. Rybicki B. Pohlman et al. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens Bone Marrow Transplant 35 2005 247-252
11. H. Glucksberg R. Storb A. Fefer et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 18 1974 295-304
12. H.M. Shulman G.E. Sale K.G. Lerner et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 91 1978 545-570
13. J.C. Byrd K. Mrozek R.K. Dodge et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 2002 4325-4336
14. M. Girgis C. Hallemeier W. Blum et al. Chimerism and clinical outcomes of 110 unrelated donor bone marrow transplant recipients conditioned with low dose (550 cGy), single exposure total body irradiation and cyclophosphamide Blood. 105 2004 3035-3041
15. R.A. Clift C.D. Buckner F.R. Appelbaum et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia J Clin Oncol 10 1992 1723-1729
16. K.T. Godder J. Mehta K.Y. Chiang et al. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant Bone Marrow Transplant 28 2001 1031-1036
17. M.B. Maris D. Niederwieser B.M. Sandmaier et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies Blood 102 2003 2021-2030
18. H.G. Sayer M. Kroger J. Beyer et al. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: Disease status by marrow blasts is the strongest prognostic factor Bone Marrow Transplant 31 2003 1089-1095
19. J. Mehta R. Powles J. Treleaven S. Kulkarni C. Horton S. Singhal Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: An important modifiable factor influencing outcome Blood 90 1997 3808-3810
20. 6 CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplant 26 2000 489-496
21. A. Dominietto T. Lamparelli A.M. Raiola et al. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation Blood 100 2002 3930-3934